What move does the options market price into Century Therapeutics's report?

Implied ±60.5%, either direction.

IPSCNasdaqBiological Products, (No Diagnostic Substances)

Century Therapeutics, Inc. (IPSC) earnings date, market-implied expected move, and options open interest by expiry

1.50

pre 1.50 −9.89%

Pre-market16:00 ETdelayed

Open1.60Volume561,307Mkt cap$273.4MEPS-0.93

Day1.50 – 1.604%52-wk0.44 – 3.0441%

IPSC

Century Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±60.5%implied · straddle

0.602.42

spot 1.51exp Nov 20ATM strike 1.5ATM straddle 1.07IV 458%

Nov 5 closethin chain

Expected move

Inputs

Next report

Nov 12

before open · in 6 days

est.Q3 FY26

Calendar

Next report

Last report

−4.85%

vs ±29.8% implied · ×0.16

shaded = implied · ▲▼ = realized

Aug 12 '26 · confirmed

Implied vs realized

Linked news

7dBMY · customerBristol Myers Squibb posts Q3 net earnings $2,162 million, diluted EPS $1.05, revenue $13,069 million

News

Largest filed tie

13F top-10 QoQ

+7.40%

shares held · 10 largest managers

13F · Jun 30 '26129d lag

100 managers

Top fund weight

0.01%

IPSC weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Century Therapeutics (IPSC) is expected to report on Nov 12 before open (estimated date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 12 '26confirmed±29.8%▼−4.85%×0.16

quarterimplied−30%0+30%realized×

Q2 FY26±29.8%▼−4.85%×0.16

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Nov 4 close

0.00OI · 4 expiries · Nov 4 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

0—Nov 2014d267—

1,3010%Jan 1570d0.811,612+6%0.81

1,897−1%Mar 19133d0.702,695+3%0.70

1,532+28%Apr 16161d2.89530+3%2.89

ExpiryPutsCallsP/C

Nov 2014d0—267—0.00

Jan 1570d1,3010%1,612+6%0.81

Mar 19133d1,897−1%2,695+3%0.70

Apr 16161d1,532+28%530+3%2.89

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±60.5%

Funds 3

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

per later filingQ1 FY25

70.13%per later filingnet margin · revenue +2516.59% QoQ · +12667.72% YoY

Revenue$109M+2516.59%

Gross profit$109M100.00%+2516.59%

Operating income$74M67.95%+298.95%

Pre-tax income$0+100.00%

Net income$77M70.13%+312.25%

Cost of revenue$0—

Operating expenses$35M−15.60%

Other income$2M−20.21%

Source: SEC filings · standardized · QE Mar 31 '25 · bars = % of revenue

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 5 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

PCE ×1.11· ±4.5% vs ±4.0% · 20 releases

eventrelease day|move|up · n×base

PCEpersonal income & outlays±4.5%9 of 20×1.11

NFPjobs report±4.3%5 of 10×1.05

GDPgross domestic product±4.2%11 of 20×1.03

PPIproducer prices±3.9%6 of 11×0.96

CPROFcorporate profits±3.6%7 of 12×0.89

CPIconsumer prices±3.1%2 of 11×0.76

FOMCrate decision±3.0%9 of 24×0.74

Bar = avg |move| to ±5% · tick = ±4.0% avg day · ×base = |move| ÷ ±4.0% · min 6 releases

Earnings history

EPS -0.17 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 12 '26 · confirmed	-0.17	—
Q1 FY26	—	-0.11	—
Q3 FY25	—	-0.40	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod